Clinical trial
Genomic and Proteomic Analysis of Programmed Cell Death Mechanisms in Peri-implant Disease
NCT06865976 is registered in ClinicalTrials.gov with Sakarya University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Genomic and Proteomic Analysis of Programmed Cell Death Mechanisms in Peri-implant Disease
- Lead sponsor
- Sakarya University
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 1, 2021
- Completion date
- September 1, 2024
- Enrollment
- 72 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
apoptosis, apoptosis regulatory proteins, peri-implantitis and peri-implant mucositis, proteases